SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-321834
Filing Date
2018-11-08
Accepted
2018-11-08 07:14:29
Documents
54
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d637149d10q.htm 10-Q 739352
2 EX-31.1 d637149dex311.htm EX-31.1 6354
3 EX-31.2 d637149dex312.htm EX-31.2 6349
4 EX-32.1 d637149dex321.htm EX-32.1 3736
5 EX-32.2 d637149dex322.htm EX-32.2 3717
  Complete submission text file 0001193125-18-321834.txt   2703108

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dcph-20180930.xml EX-101.INS 325752
7 XBRL TAXONOMY EXTENSION SCHEMA dcph-20180930.xsd EX-101.SCH 31845
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dcph-20180930_cal.xml EX-101.CAL 47016
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dcph-20180930_def.xml EX-101.DEF 101296
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE dcph-20180930_lab.xml EX-101.LAB 269075
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dcph-20180930_pre.xml EX-101.PRE 188183
Mailing Address 500 TOTTEN POND ROAD WALTHAM MA 02451
Business Address 500 TOTTEN POND ROAD WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Filer) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38219 | Film No.: 181168152
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1